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Abstract 27	
Cyclic dinucleotides are highly versatile signaling molecules in both prokaryotes and eu-28	
karyotes involved in the control of various important biological processes. The best-studied 29	
example is bis-(3′-5′)-cyclic dimeric GMP (c-di-GMP). Known since the late 1980’s it is now 30	
recognized as near-ubiquitous second messenger in bacteria that coordinates diverse aspects 31	
of bacterial growth and behavior including motility, virulence, biofilm formation or cell cycle 32	
progression. In this Review, we discuss important new insights into the molecular principles 33	
of c-di-GMP synthesis and degradation, and its function in cellular control and give a short 34	
overview on the signaling versatility of other CDNs including c-di-AMP, cAMP-GMP and 35	
cGAMP.  36	
 37	
Introduction 38	
The roles of the prototypical second messengers cAMP and cGMP have been studied for 39	
over 50 years, whereas recognition of their larger relatives, the cyclic dinucleotides (CDNs), 40	
lagged behind. The first CDN was discovered in 1987, when Moshe Benziman reported on 41	
“an unusual cyclic nucleotide activator” that was able to stimulate cellulose synthase from 42	
Acinetobacter xylinum and identified this compound as bis-(3’-5’)-cyclic diguanylic acid (c-43	
di-GMP)1. More than 20 years later, c-di-AMP was discovered as a factor involved in DNA 44	
repair in Bacillus subtilis2. Moreover, different versions of c-GMP-AMP (cGAMP) were first 45	
discovered in bacteria3 and later in mammalian cells4 and were shown to have prominent roles 46	
in bacterial virulence and the innate immune response. Despite of their chemical similarities, 47	
different CDNs seem to have distinct evolutionary origins with enzymes involved in their 48	
synthesis and breakdown being structurally unrelated2,5,6. The idea that different CDNs 49	
evolved in parallel emphasizes the potency and versatility of this macrocyclic ring with two 50	
purine moieties as key carrier of cellular information. 51	
The discovery of CDNs has provided novel entry points into studying important biologi-52	
cal processes and cell behavior, including how bacteria coordinate their own growth and rep-53	
lication cycle, how they adapt to surfaces by forming multicellular consortia called biofilms, 54	
or how pathogenic bacteria control their virulence and persistence. This was possible by first 55	
identifying the enzymes involved in CDN synthesis and degradation, followed by the charac-56	
terization of specific effectors and target molecules. The CDN field is now rapidly expanding 57	
into different directions exploring signaling aspects at the atomic, molecular and cellular lev-58	
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els. In the past years, we have learned that CDNs are widespread and immensely versatile 59	
signaling molecules that regulate cellular processes at multiple levels of control and that are 60	
well integrated with other global regulatory pathways in bacteria like phosphorylation net-61	
works7, quorum sensing8 or with other small signaling molecules like cGMP, cAMP or 62	
ppGpp9-11. In this Review, we discuss some of the recent advances in CDN biology without 63	
the claim to be comprehensive and with a primary focus on aspects of c-di-GMP signaling. C-64	
di-GMP is not only the most widespread CDN in bacteria but so far is also the most intensely 65	
studied and best understood member of this family of second messengers. We first summarize 66	
properties of the core components of c-di-GMP signaling, enzymes involved in its synthesis 67	
and breakdown as well as effector proteins that convert dynamic changes of c-di-GMP con-68	
centrations into specific cellular responses. We then highlight recent progress in understand-69	
ing the most prominent cellular processes regulated by c-di-GMP. While we draw some paral-70	
lels between c-di-GMP and other CDNs, c-di-AMP signaling in bacteria and the role of 71	
cGAMP in the mammalian innate immune response will not be discussed in detail. Instead we 72	
refer readers to some excellent and comprehensive recent reviews on CDNs and their promi-73	
nent role in bacterial physiology2,4,12-16. 74	
 75	
Makers and breakers 76	
The c-di-GMP monomer shows 2-fold symmetry with two GMP moieties fused by a 5’-77	
3’ macrocyclic ring (Fig. 1a). High-resolution structures of c-di-GMP, in solution or bound to 78	
protein, indicated that the ligand exists either as elongated monomer or as condensed interca-79	
lated dimer3,17. At physiological concentrations c-di-GMP is a monomer in solution4,18 argu-80	
ing that intercalated dimers form by successive binding of two molecules to specific effector 81	
proteins. Cellular levels of c-di-GMP are regulated in response to environmental and internal 82	
cues. This is achieved through the activity of two antagonistic enzyme families, diguanylate 83	
cyclases (DGCs) and c-di-GMP specific phosphodiesterases (PDEs) (Figure 1a) with equiva-84	
lent enzyme activities being responsible for c-di-AMP metabolism (Box 2). DGCs and PDEs 85	
are found in members of all major bacterial phyla, representing two of the largest known fam-86	
ilies of signaling proteins in the bacterial kingdom2,5,6,12. The synthesis of c-di-GMP is cata-87	
lyzed by DGCs through the cooperative action of two catalytic GGDEF domains that arrange 88	
in an antiparallel fashion with one GTP molecule bound by each protomer. Pioneering struc-89	
tural and mechanistic studies with PleD, a DGC from Caulobacter crescentus, proposed 90	
modes of substrate binding, catalytic mechanism, enzyme activation and product inhibition 91	
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for this class of enzymes5,7,19-21. A metal-catalyzed mechanism was proposed, whereby two 92	
GTP molecules are positioned in an antiparallel manner to enable the formation of two inter-93	
molecular phosphodiester bonds8,22 (Figure 1b). The requirement for dimerization conveys a 94	
simple mechanism to control DGC activity by using an accessory domain that forms ho-95	
modimers in a signal-dependent manner. In the case of PleD or its Pseudomonas aeruginosa 96	
homolog WspR this is facilitated by an N-terminal receiver domain, which dimerizes upon 97	
phosphorylation5,9-11,19,23 (Figure 1b). An alternative mechanism for the activation of DGCs 98	
was proposed recently for DgcZ from Escherichia coli, an enzyme with a catalytic GGDEF 99	
domain fused to an N-terminal zinc-binding (CZB) domain. DgcZ is a constitutive dimer with 100	
its activity being allosterically regulated by the CZB domain22 (Figure 1c). When zinc is pre-101	
sent, the GGDEF domains of DgcZ, although facing each other, are not positioned in a cata-102	
lytically competent conformation. DgcZ activation in the absence of zinc may occur via repo-103	
sitioning of the GGDEF domains to enable the productive encounter of bound substrates mol-104	
ecules (Figure 1b). 105	
The arrangement of the catalytic GGDEF domains was also implicated in feedback inhi-106	
bition. Many of these enzymes are subject to non-competitive product inhibition by binding of 107	
c-di-GMP to the allosteric I-site on the surface of the GGDEF domain5,21. In PleD or WspR, 108	
an intercalated c-di-GMP dimer binds to this primary site and to a secondary binding site 109	
thereby immobilizing the GGDEF domains in a non-productive state19,23 (Figure 1b). Product 110	
inhibition of DGCs may establish precise cellular threshold concentrations of c-di-GMP or 111	
contribute to the reduction of stochastic perturbations and increased stability of c-di-GMP 112	
networks by maintaining c-di-GMP levels in defined concentration windows21. While a func-113	
tional connection between the I-site and product inhibition is clearly established, c-di-GMP 114	
binding to some GGDEF domains may also serve other purposes like protein-protein interac-115	
tion24 (see chapter on receptors, below).  116	
Structurally and mechanistically distinct c-di-GMP specific PDEs have been described 117	
that are based on EAL and HD-GYP domains, respectively. EAL-type PDEs hydrolyze c-di-118	
GMP in the presence of Mg2+ or Mn2+ to yield the linear pGpG dinucleotide25. EAL domain-119	
containing proteins are active as dimers26,27. But in contrast to DGCs, where the fusion of two 120	
GTP molecules requires a dimer arrangement of the enzyme, the necessity of this quarternary 121	
arrangement for PDE catalysis is not intuitive. Recent structural studies implied a regulatory 122	
role for EAL dimerization. Based on distinct structural arrangements of EAL dimers, a clam-123	
shell-like opening and closing of the EAL dimer was proposed to regulate PDE activity27,28. 124	
The evolutionary conserved dimerization interface is formed by two helices, α5 and α6, with 125	
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α5 directly connecting via the β5-α5 loop (loop 6) to two central Asp residues that coordinate 126	
the metal ions in the active site26,27,29 (Figure 1d). Structural and biophysical studies revealed 127	
that the α5-loop6 region undergoes substantial rearrangements during the clam-like move-128	
ments of the EAL dimer, indicating that this part of the protein may play a hinge-joint-like 129	
role to couple EAL conformation to catalytic activity via the positioning of metal ions in the 130	
active site27,28. Consistent with this, accessory domains known to control PDE activity directly 131	
communicate with the EAL dimerization region28. The observation that substrate binding can 132	
induce EAL dimerization and also determines the conformation of the α5-loop6 region pro-133	
posed a bidirectional allosteric communication between EAL domains and regulatory do-134	
mains with the α5-loop6 region serving as central communication platform27-29. Interestingly, 135	
EAL domain-containing proteins that have adopted roles as c-di-GMP effectors seem to ex-136	
ploit similar c-di-GMP–mediated dimerization and α5-loop6 remodeling to regulate cellular 137	
processes30 (see below). 138	
A second, unrelated family of c-di-GMP-specific phosphodiesterase harbors conserved 139	
HD-GYP domains31. Recently, the first structure of an active HD-GYP PDE was solved im-140	
plicating a novel trinuclear iron-binding site in catalysis32. While EAL-based enzymes convert 141	
c-di-GMP into the linear product pGpG, HD-GYP hydrolyzes c-di-GMP in a one-step reac-142	
tion to yield two molecules of GMP32. Thus, for bacteria that lack HD-GYP-domain proteins 143	
it remained unclear how pGpG is further catabolized into GMP. This puzzle was solved re-144	
cently by demonstrating that the oligoribonuclease Orn, a ribonuclease hydrolyzing two- to 145	
five-nucleotide-long RNAs, is the primary enzyme capable of removing pGpG33,34.  146	
Despite detailed knowledge on structure and function of DGCs and PDEs, it has re-147	
mained challenging to assign physiological roles to individual enzymes under laboratory con-148	
ditions. Genetic studies often fail to disclose clear phenotypes. Since only few specific input 149	
signals have been identified for these enzymes so far, this may be due to the limited physio-150	
logical conditions that are assayed in the laboratory. Evidence for this was provided by a re-151	
cent study of PDEs in E. coli. Despite of a total of 13 PDEs being encoded in the genome of 152	
this organism, only PdeH is able to reduce c-di-GMP levels and license motility in growing E. 153	
coli cells35,36 (see below). The observations that most PDEs are readily expressed and that a 154	
large fraction of these enzymes can be genetically activated to substitute for PdeH in motility 155	
control implied that most of these enzymes simply lack the appropriate stimuli under labora-156	
tory conditions37. DGCs and PDEs also engage in downstream signaling through direct inter-157	
actions with their target molecules thereby providing a platform for “spatially localized” con-158	
trol of cellular processes24,38,39. Within such supra-molecular complexes, these proteins not 159	
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only regulate the synthesis and degradation of c-di-GMP, but can also act as “c-di-GMP sen-160	
sors” to control neighboring partner proteins39.  161	
 162	
C-di-GMP receptors 163	
While "makers and breakers" explain how c-di-GMP levels are controlled in time and 164	
space, c-di-GMP pathways ultimately hinge on the respective effectors that bind c-di-GMP 165	
and on their downstream targets, cellular components that are regulated by specific c-di-GMP 166	
effectors. Given the global influence of c-di-GMP on bacterial cell physiology and given the 167	
sheer abundance of DGCs and PDEs in some bacteria, it must be assumed that a large number 168	
of such effectors and cellular targets exist. Several families of effector proteins and RNAs 169	
have been identified and are now well characterized structurally and functionally40. This in-170	
cludes mRNA riboswitches41, transcription regulators42, proteins containing PilZ domains, a 171	
small prototypical c-di-GMP binding unit36,43,44 and proteins harboring degenerate GGDEF 172	
and EAL domains45. With one of these examples the field has recently come full circle. The 173	
discovery of c-di-GMP goes back to the observation that c-di-GMP activates the membrane-174	
bound BcsAB cellulose synthase complex in Gluconacetobacter xylinus thereby boosting the 175	
production of this exopolysaccharide matrix component1. The availability of the structure of 176	
the BcsAB complex now revealed an elegant mechanism, whereby c-di-GMP binding to the 177	
C-terminal PilZ domain of BcsA releases autoinhibition of the glycosyltransferase activity to 178	
activate the complex46 (Figure 1e). This example illustrates how c-di-GMP effectors such as 179	
PilZ or the newly discovered YajQ protein family47 can act as versatile adaptors that link c-di-180	
GMP signal input to the activity of enzymes complexes or transcription factors.  181	
The discovery that c-di-GMP binds to a range of transcription factors such as members of 182	
the response regulator or CRP/FNR families in a way that was not predictable from protein 183	
sequence, argued for a more versatile nature of effector-ligand interactions48-50. This is sup-184	
ported by the identification and characterization of a range of novel c-di-GMP effectors, an 185	
endeavor that was greatly aided by the introduction of innovative high-throughput methods 186	
and biochemical techniques (Box 1). One of the most exciting recent discoveries is the emer-187	
gence of ATPases as molecular targets of c-di-GMP. The first example is FleQ, a bacterial 188	
enhancer-binding protein from P. aeruginosa. While members of this family of transcription 189	
factors are normally activated by phosphorylation, FleQ activity is controlled by c-di-GMP51. 190	
Structural studies revealed that the second messenger interacts with the AAA+ ATPase do-191	
main of FleQ at a site distinct from the ATP binding pocket. Binding of c-di-GMP obstructs 192	
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FleQ ATPase activity, thereby altering its quaternary structure and transcriptional activity50. 193	
Similarly, c-di-GMP specifically binds to MshE, an AAA+ ATPase involved in the assembly 194	
of mannose sensitive hemagglutinin (MSHA) pili in Vibrio cholerae52,53. The observation that 195	
HxrA, a MshE homolog and type 2 secretion (T2S) ATPase from P. aeruginosa also specifi-196	
cally binds c-di-GMP opened up the exciting possibility that this general protein secretion 197	
pathway that employs a pilus-like extrusion mechanism might also be controlled directly by 198	
c-di-GMP52. The idea that c-di-GMP might have taken a more global control over bacterial 199	
protein secretion is reinforced by some recent observations indicating that this second mes-200	
senger also controls Type 6 (T6S)54 as well as Type 3 secretion (T3S)55. While the exact role 201	
of c-di-GMP in T6S is yet unclear, its influence on T3S seems to be direct and again mediated 202	
via a central ATPase. It was shown that the flagellar export ATPase FliI from a range of dis-203	
tantly related bacteria specifically bind c-di-GMP55. Binding of c-di-GMP to FliI and to its 204	
homolog HrcN from the virulence related T3SS inhibits ATPase activity arguing that it direct-205	
ly interferes with flagellar export and T3S. The authors of this study proposed that the c-di-206	
GMP binding arrangement might be widely conserved among the rotary export ATPases, 207	
making the second messenger central to the function of many of these secretion proteins. It 208	
will be interesting to compare the c-di-GMP binding mode of the individual members of this 209	
family once structural information is available. Finally, sensor histidine kinases, the central 210	
components of phosphorylation pathways in bacteria, have also been identified as c-di-GMP 211	
targets. The histidine kinase CckA from C. crescentus was shown to bind c-di-GMP via its 212	
catalytic and ATPase domain, thereby shifting the kinase/phosphatase balance of this bifunc-213	
tional enzyme7 (see below). The discovery that ATPases serve as regulatory hubs for c-di-214	
GMP may reflect on the global role of c-di-GMP in monitoring bacterial cell physiology. 215	
ATPases often function as central regulatory switches governing key cellular processes. Ap-216	
parently, c-di-GMP leverages part of its global influence by seizing control over these essen-217	
tial cellular players.  218	
 219	
Physiological roles of c-di-GMP  220	
Development and morphogenesis 221	
Several bacteria make use of c-di-GMP to control morphogenesis and developmental 222	
transitions. This includes Caulobacter crescentus, an aqueous organism with an inherently 223	
asymmetric life cycle. C. crescentus produced two specialized progeny cells during each divi-224	
sion cycle, a motile swarmer (SW) and a sessile stalked cell (ST). Predivisional cells of C. 225	
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crescentus are highly polarized with a stalk and adhesive holdfast exposed at one cell pole 226	
and a flagellum, pili and a chemotaxis apparatus assembled at the opposite pole. While the 227	
surface attached ST progeny re-initiates chromosome replication (S-phase) and cell division 228	
(G2-phase) immediately following division, the newborn SW cell is motile but blocks replica-229	
tion throughout an extended period (G1-phase). Replication and division resume when the 230	
SW cell differentiates into a ST cell, a process during which it ejects its flagellum, retracts its 231	
pili and replaces them with a holdfast and a stalk56 (Figure 2). Recent studies identified c-di-232	
GMP as a major driver of C. crescentus pole morphogenesis and cell cycle control7,57,58. Mu-233	
tants unable to synthesize c-di-GMP lost all polar appendages and showed striking cell mor-234	
phology aberrations58. Levels of c-di-GMP oscillate during the C. crescentus cell cycle with 235	
trough values in the motile SW, a peak during the swarmer-to-stalked cell transition and in-236	
termediate concentrations during division58,59 (Figure 2). The increase in c-di-GMP concen-237	
tration during the SW-to-ST transition is produced primarily by PleD, a DGC that is activated 238	
when cells enter S-phase58,60. PleD activity is confined to the ST cell by two antagonistic his-239	
tidine kinases, PleC and DivJ, which position to opposite poles of dividing cells and differen-240	
tially segregate into SW and ST progenies (Figure 2). While PleC acts as phosphatase keeping 241	
PleD~P levels low in SW cells, DivJ acts as kinase to impel PleD phosphorylation in ST 242	
cells60. Counteracting PDEs are thought to keep c-di-GMP levels low in the motile SW cell. 243	
One of these, PdeA, localizes to the flagellated pole before division and later partitions into 244	
the newborn SW cell where it authorizes motility by keeping c-di-GMP levels low. PdeA is 245	
removed by specific proteolysis during the SW-to-ST transition coincident with PleD activa-246	
tion, thereby contributing to the sharp upsurge of c-di-GMP at this stage of the cell cycle57. 247	
But how does c-di-GMP oscillation instigate the exact timing of C. crescentus cell cycle 248	
events? The TipF-TipN pathway regulating flagellar polarity illustrates such an example. Up-249	
on binding of c-di-GMP, TipF localizes to the pole opposite of the stalk where it connects 250	
with its polar receptor, the birth scar protein TipN61. TipF then recruits flagellar proteins to 251	
this subcellular site to initiate flagellar assembly in the predivisional cell. TipF is stable when 252	
bound to c-di-GMP but is rapidly degraded when c-di-GMP levels drop in the SW cell. Re-253	
moval of TipF was proposed to reset the flagellar polarization state and to avoid misposition-254	
ing of the flagellar motor at the incipient stalked cell pole61 (Figure 2). Recent studies also 255	
linked c-di-GMP oscillations to the G1-S cell cycle transition and chromosome replication 256	
control. The transcription factor CtrA acts as inhibitor of replication initiation in C. crescen-257	
tus. CtrA is phosphorylated and active in swarmer cells (G1) where it binds to the origin of 258	
replication (Cori) to block replication initiation56. During differentiation into ST cells, CtrA is 259	
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inactivated to license replication start. CtrA activity is controlled by the bifunctional cell cycle 260	
histidine kinase CckA, which phosphorylates CtrA through the phosphotransfer protein ChpT. 261	
CckA exhibits kinase activity in the SW cell but adopts strong phosphatase activity during the 262	
G1-S transition, thereby reversing the phosphate flux through the CckA-ChpT-CtrA cascade 263	
and inactivating CtrA. Concurrent with its dephosphorylation, CtrA is degraded by the ClpXP 264	
protease56. Both dephosphorylation and degradation of CtrA are controlled by the c-di-GMP 265	
upshift during G1-S. While degradation is mediated by the ClpXP protease adaptor PopA, 266	
which binds to c-di-GMP and delivers CtrA to the protease45,62,63, CtrA inactivation results 267	
from c-di-GMP directly interfering with the CckA kinase-phosphatase switch. Biochemical 268	
and structural studies demonstrated that c-di-GMP binds to CA domain of CckA, thereby in-269	
hibiting its default kinase activity and stimulating phosphatase activity (Figure 2)7. In addition 270	
to adopting a cyclin-like role to drive G1-S, c-di-GMP imposes spatial control on CckA dur-271	
ing division to install asymmetric replication of future daughter cells. In predivisional cells 272	
CckA positions to opposite cell poles, adopting kinase and phosphatase activity at the flagel-273	
lated and stalked pole, respectively. This leads to a gradient of CtrA~P in the cell and to 274	
asymmetric replication initiation with the Cori at the ST pole being activated before cell divi-275	
sion is completed, while the Cori at the flagellated pole remains inactive64,65. The unequal dis-276	
tribution of c-di-GMP was proposed to control differential activity of CckA at opposite poles. 277	
While the bulk of dividing cells experiences high levels of c-di-GMP, a microenvironment 278	
with low levels of c-di-GMP was proposed to promote CckA kinase activity at the flagellated 279	
pole7 (Figure 2). The authors of this study proposed that CckA sequestration to the flagellated 280	
pole could shield the protein from the cellular pool of c-di-GMP. How such a low c-di-GMP 281	
microenvironment is organized and which PDEs are involved in this spatial control remains to 282	
be shown.  283	
Asymmetric distribution of c-di-GMP during cell division was also observed in other 284	
bacteria arguing that this might represent a general principle controlling cell behavior and/or 285	
reproduction59. For example, during the P. aeruginosa cell cycle, c-di-GMP levels drop dur-286	
ing a short period after cell division in the daughter cell that inherits the polar flagellum. This 287	
pattern is caused by the asymmetric distribution of Pch, a PDE that during division localizes 288	
to the chemotaxis machinery at the flagellated cell pole66. Akin to the G1 period of the Cau-289	
lobacter cell cycle, reduction of c-di-GMP at this stage of the P. aeruginosa division cycle 290	
may promote diversity in the swimming behavior, which in turn could help to adapt to new 291	
environments. 292	
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Streptomycetes undergo a complex life cycle with two distinct filamentous cell forms. Ger-293	
minating spores develop into vegetative hyphae, which grow into the substrate to scavenge 294	
nutrients. Upon nutrient depletion aerial hyphae are formed, which eventually differentiate in-295	
to long chains of spores67. Recently, c-di-GMP was found to have a key role in the transition 296	
from vegetative mycelial growth to the formation of a reproductive aerial mycelium42. Dele-297	
tion of genes encoding proteins involved in c-di-GMP metabolism had a notable effect on 298	
colony morphology and development 67. Moreover, increasing internal levels of c-di-GMP 299	
blocked development, while depleting c-di-GMP caused premature spore production bypass-300	
ing the formation of aerial hyphae42. Premature sporulation is also observed in mutants lack-301	
ing BldD, the master regulator of Streptomyces development that represses a global regulon of 302	
~170 sporulation genes67. Recently, a direct connection between these two key components of 303	
developmental control was identified when BldD was shown to be a c-di-GMP effector pro-304	
tein that represses its target genes in a manner that depends on its binding to c-di-GMP42. A 305	
drop in cytoplasmic c-di-GMP levels, which causes the BldD dimer to fall apart and dissoci-306	
ate from the DNA, may then trigger BldD inactivation and sporulation. Other examples illus-307	
trating the broad impact of c-di-GMP on development and morphogenesis in bacteria include 308	
Myxococcus xanthus68, Bdellovibrio bacteriovorus69 or cyanobacteria70.  309	
 310	
Motile-sessile transition and biofilm formation. 311	
Controlling the motile-sessile transition of bacteria is a universal feature of c-di-GMP. 312	
Generally, low levels of c-di-GMP are associated with motility of individual cells, while in-313	
creased c-di-GMP concentrations direct bacteria into surface attached communities and bio-314	
films. But rather than being a simple on/off switch, complex regulatory steps seem to be in-315	
volved in a multi-stage process leading to surface colonization71. In line with motility being a 316	
primary target of c-di-GMP, building and operating the bacterial flagellar motor is highly reg-317	
ulated. This includes regulation of flagellar gene expression49,51, motor assembly55,61 or motor 318	
function36,72. While controlling flagellar gene expression is likely to be part of a long-term ad-319	
aptation strategy, tuning motor activity might be important for rapid decisions during bacterial 320	
surface encounter. For example, in E. coli and Salmonella enterica increased c-di-GMP levels 321	
result in flagellar obstruction by the c-di-GMP effector protein YcgR, which in its c-di-GMP-322	
bound form interacts with the flagellar rotor/stator interface36,73 (Figure 3a). To block YcgR 323	
activity and to authorize swimming these bacteria co-express the PDE PdeH together with 324	
their flagellar genes. A similar mechanisms was proposed to tune motility in Bacillus subtilis, 325	
where PdeH controls motility by preventing flagellar obstruction by the YcgR homolog 326	
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DgrA74. YcgR has high ligand affinity arguing that the flagellar motor may respond to small 327	
spikes of c-di-GMP that are required to initiate surface attachment. Consecutive steps of sur-328	
face colonization may involve incremental steps of c-di-GMP increase and the sequential ac-329	
tivation of distinct cellular processes. This could be accomplished by a successive interven-330	
tion of DGCs harboring distinct levels of feedback inhibition21 and by the activation of c-di-331	
GMP receptors with gradually reduced affinities75. For example, in P. aeruginosa different 332	
DGCs, PDEs and receptor proteins are required at discrete stages of biofilm formation71. 333	
Upon surface contact, bacteria rapidly change their program, expose adhesins, activate 334	
surface motility organelles and produce an extracellular matrix to protect the developing mi-335	
crocolonies. This adaptation is coordinated by c-di-GMP at the transcriptional (e.g.76), transla-336	
tional (e.g.77) and posttranslational level (e.g.78). For example, c-di-GMP regulates Type IV 337	
pili (T4P), the prototypical surface adherence and motility organelles, in various bacteria in-338	
cluding M. xanthus79, V. cholera53, P. aeruginosa80, C. crescentus58 or Clostridium difficile81 339	
(Figure 4). Likewise, in E. coli the production of the two principle biofilm matrix compo-340	
nents, curli fibers and cellulose, is regulated by c-di-GMP82. During the motile-sessile switch, 341	
c-di-GMP levels increase as a result of σS-induced expression of DgcE and other DGCs and 342	
the consecutive downregulation of the PDE PdeH, which acts as gatekeeper for motility and is 343	
part of the large flagellar regulon36,83 (formerly: YegE and YhjH35). Increased global c-di-344	
GMP levels then set in motion a local control module consisting of DgcM and PdeR, a 345	
DGC/PDE pair that directly interacts with and stimulates the transcription factor MlrA, which 346	
in turn activates the expression of the central curli regulator CsgD. Interestingly, the role of 347	
PdeR and DgcM is not primarily a catalytic one but rather to sense the global increase in c-di-348	
GMP and in response serve as co-activators for MlrA39. CsgD then mediates transcription of 349	
curli genes and at the same time induces the expression of DgcC, the primary DGC to allo-350	
sterically activate cellulose production via the cellulose synthase complex (Figures 1e, 3b)46. 351	
This is a prime example of how different levels of the c-di-GMP network are interconnected 352	
to generate highly flexible and expanding responses, which in this case enable for differential 353	
tuning of individual matrix components. An alternative exopolysaccharide, poly-beta-1,6-N-354	
acetyl-glucosamine (PGA) can promote E. coli surface adherence and biofilm formation. 355	
PGA biogenesis and secretion requires the Pga complex (PgaA-D) and its allosteric activation 356	
by c-di-GMP. Both the pgaABCD operon and two DGCs, DgcT and DgcZ, are controlled by 357	
Csr, a global regulatory system that mediates E. coli virulence and biofilm formation84. Re-358	
cent findings indicated that c-di-GMP activates the Pga machinery by binding directly to both 359	
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PgaC and PgaD, the two inner membrane components of the Pga complex to stimulate their 360	
glycosyltransferase activity78 (Figure 3c). 361	
While the processes driving biofilm formation are relatively well understood, mecha-362	
nisms underlying biofilm dispersal have remained understudied. Given the prominent role of 363	
c-di-GMP in biofilm formation, careful control of the second messenger must also be linked 364	
to active biofilm dispersal85. Such an escape mechanism was identified in Pseudomonas fluo-365	
rescens, where the LapA surface protein mediates surface adhesion and stabilization of bio-366	
films86. At high c-di-GMP levels, c-di-GMP binds to LapD to help sequester the LapG prote-367	
ase in the periplasm. When c-di-GMP levels drop upon induction of the PDE RapA, LapD is 368	
inactivated thereby releasing the protease to cleave the LapA adhesin and to weaken the bio-369	
film (Figure 3d). 370	
As biofilms contribute to acute and chronic infections, it is not surprising that the c-di-371	
GMP network is under selective pressure in human patients. Slow growing, autoaggregative 372	
P. aeruginosa isolates from airways of patients with cystic fibrosis were shown to harbor mu-373	
tations leading to strong activation of some of the major DGCs87,88. The observation that such 374	
variants effectively persisted in animal models and in the presence of sub-inhibitory concen-375	
tration of antibiotics, despite of reduced growth rates in vitro, indicated that they may have an 376	
important role in persistence during antimicrobial chemotherapy87.  377	
 378	
Role of c-di-GMP in bacterial virulence  379	
C-di-GMP modulates virulence of animal and plant pathogens12. Processes controlled by 380	
c-di-GMP include host cell adherence, secretion of virulence factors, cytotoxicity, invasion, 381	
resistance to oxidative stress, and modulation of the immune response. Importantly, recent 382	
findings have linked c-di-GMP to the most prominent secretion systems for virulence factors 383	
including T2SS, T3SS and T6SS52,54,55. This opens up the possibility that c-di-GMP interferes 384	
with these processes on a more global scale. An emerging example for the importance of c-di-385	
GMP in virulence is Clostridium difficile. In contrast to most Gram-positive bacteria C. dif-386	
ficile encodes a large number of enzymes involved in c-di-GMP turnover 89. In the course of 387	
infections, C. difficile undergoes a c-di-GMP-mediated switch from a motile to a surface ad-388	
herent state with cells adhering to the intestinal mucosa via T4P and other adhesins90. This 389	
transition is mediated by a total of 16 c-di-GMP-responsive riboswitches, 12 of which being 390	
OFF switches (Type I) and four being ON switches (type II)91. Through these regulatory ele-391	
ments, c-di-GMP controls the expression of flagella, pili, adhesion factors and other virulence 392	
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factors including toxins TcdA and TcdB, the main virulence factors of C. difficile81,91-94 (Fig-393	
ure 4). For example, a collagen binding protein (CBP) and its specific protease are inversely 394	
controlled by Type I and II riboswitches, respectively91. Expression of the protease at low c-395	
di-GMP concentrations effectively prevents host cell adherence, while expression of the CBP 396	
at high c-di-GMP concentrations promotes attachment to host tissue. Thus, c-di-GMP-397	
mediated riboswitches control C. difficile host colonization by coordinating motility, toxin 398	
production, surface adhesion and biofilm formation. 399	
Another example for the prominent role of c-di-GMP in virulence is the 2011 German 400	
outbreak of E. coli O104:H4, which caused a unusually high incidence of haemolytic uraemic 401	
syndrome (HUS)95. The genome of the causative strain showed characteristics of both enter-402	
haemorrhagic E. coli (EHEC) and enteroaggregative E. coli (EAEC) and revealed the pres-403	
ence of a highly expressed diguanylate cyclase (dgcX), which is prevalent in EAEC O104:H4 404	
strains96. This indicated that the outbreak strain and EAEC in general produce high levels of 405	
c-di-GMP and likely form biofilms in the host. The observation that the dgcX gene is inserted 406	
at the attB locus, the integration site for phage lambda, and is flanked by prophage elements, 407	
suggested acquisition by horizontal gene transfer. The analysis of E. coli O104:H4 also em-408	
phasized the key importance of adaptation and regulatory flexibility of the c-di-GMP net-409	
work. While strong adherence, together with Shiga-toxin expression, is a key virulence factor 410	
of E. coli O104:H4, this strain produces curli but is cellulose negative. The authors of this 411	
study speculated that the strong pro-inflammatory effect of curli together with the absence of 412	
cellulose (which normally counteracts this effect) may facilitate entry into the bloodstream 413	
and kidneys where this pathogen can cause life-threatening hemolytic uremic syndrome96. 414	
Given their unique distribution in bacteria and their importance in bacterial virulence it is not 415	
surprising that bacterial CDNs did not go unnoticed by the host’s immune system. Recent ev-416	
idence points to a prominent role for c-di-GMP and c-di-AMP as PAMPs, pathogen-417	
associated molecular patterns that are specifically recognized by the innate immune system of 418	
the host (Box 2). 419	
 420	
Conclusion and outlook 421	
Above we have summarized some of the recent findings describing mechanistic and func-422	
tional aspects of c-di-GMP signaling in bacteria. Although c-di-AMP was discovered more 423	
recently, the field is picking up rapidly exposing comparable physiological complexity (Box 424	
2). It is possible that additional CDNs still await their discovery offering even greater signal-425	
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ing diversity by varying either the nucleotide composition or linkage chemistry. But why are 426	
CDNs so prevalent in controlling important biological processes in bacteria? One major ad-427	
vantage of second messenger-based networks over other information transfer systems based 428	
on protein-protein interaction might be the ease with which they are able to evolve. For ex-429	
ample, recruiting additional cellular processes into an existing c-di-GMP network seems rela-430	
tively straightforward, considering that c-di-GMP often binds on the surface of pre-existing 431	
protein domains with only a few amino acids contributing to ligand affinity and specificity 432	
(Figure 5a). Simple recruitment of additional effectors together with the rapid expansion of 433	
makers and breakers by gene duplication might thus have predisposed CDN-based regulatory 434	
networks for the coordination of global metabolic and behavioral transitions in bacteria. 435	
CDN based second messengers also offer various advantages in signal transduction. Their 436	
rapid cellular diffusion stages an instantaneous and global internal response. At the same time 437	
CDNs may act in a highly specific manner either through temporal or spatial control. For ex-438	
ample, the combination of DGCs or PDEs with distinct inhibition constants and substrate af-439	
finities, respectively, together with effector proteins or RNAs of matching c-di-GMP affinities 440	
would permit cells to regulate different processes in a highly specific manner (Figure 5b). Al-441	
ternatively, spatial organization with DGCs and/or PDEs interacting directly with their re-442	
spective targets in combination with effective mechanisms isolating individual signaling 443	
modules from each other would permit parallel CDN signaling modules with highly specific 444	
readouts (Figure 5c). CDNs like c-di-GMP control the expression, activity, stability, localiza-445	
tion or interaction of specific proteins (e.g.42,61,78,97). Moreover, c-di-GMP can control the 446	
same biological process at different levels including transcription, translation or allosteric 447	
control (Figure 5d) (e.g.52). Such a multi-layered signaling architecture can impose tight con-448	
trol and continuous evaluation power over strictly unidirectional cellular processes like cell 449	
cycle progression or processes with considerable metabolic cost like the motile-sessile switch. 450	
It can also provide bacteria with the ability to rapidly sample the environment and to adjust 451	
their behavior without the need for de novo protein synthesis. Or it could serve to integrate 452	
two distinct processes but at the same time uncouple them if necessary by the use of distinct 453	
DGC/PDE modules (Figure 5d). An example of such a process is illustrated by the production 454	
of E. coli curli and cellulose (see above). Finally, it could be used to define activity windows 455	
for specific cellular processes, for example by sequential expression control (module 1) and 456	
inactivation of a downstream effector (module 2), which is either turned off by c-di-GMP or 457	
subject to c-di-GMP mediated degradation. 458	
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Despite the advances in the CDN field, many important questions remain to be addressed 459	
in the future. For example, are there additional CDNs to be included in this emerging signal-460	
ing paradigm? Which cellular activities do specific CDN networks control and how extensive-461	
ly do these compounds interfere with basic cellular processes in bacteria? What is the exact 462	
architecture of CDN networks and how do they contribute to the highly dynamic behavior of 463	
bacterial cells? And how do CDN-based networks integrate with other signaling networks like 464	
quorum sensing, phosphorylation cascades or regulation by ppGpp? It is safe to predict that 465	
this field of research will continue to provide exciting novel insights into bacterial signaling, 466	
growth and behavior. 467	
 468	
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Box 1: Toolkit for CDN analysis  470	
Several novel approaches were developed in the past years to identify and characterize 471	
CDN effector proteins on a global scale. This included affinity pull-downs followed by sub-472	
sequent mass spectrometry analysis. Trivalent chemical scaffolds with a CDN binding, a bio-473	
tin sorting, and a crosslinking moiety were used as capture compounds in combination with 474	
strepdavidin coated magnetic beads98,99. A similar approach used c-di-GMP coated sepharose 475	
beads for affinity pull-down100. The advantage of these methods is that potential binding pro-476	
teins can directly be isolated from cell extracts without the need for time consuming fractiona-477	
tion or biochemical purification. Moreover, once specific binding proteins have been identi-478	
fied, such pull-down methods can also be employed for diagnostic purposes in combination 479	
with specific antibodies78. Both methods were successfully applied with different bacteria in-480	
cluding Pseudomonas, Caulobacter, Listeria, Streptomyces or Bdellovibrio42,98,101,102. A more 481	
indirect approach made use of the complete ORFeome and subsequent testing of cell lysates 482	
with a high-throughput binding assay52,103. Differential radial capillary action of ligand assay 483	
(DRaCALA) was developed to directly mix proteins with (radio)-labeled nucleotide(s) on a 484	
nitrocellulose membrane. Upon washing the filters free ligand will diffuse away, while ligand 485	
specifically bound by proteins will be immobilized at contact site103. Application of these 486	
techniques as well as more conventional approaches like Isothermal Titration Calorimetry 487	
(ITC) or Microscale Thermophoresis (MST) have led to the identification of a plethora of 488	
novel effector proteins52,55,100,104.  489	
Several tools and biomarkers were established for in vitro and in vivo analysis of c-di-490	
GMP. This includes sensitive high performance liquid chromatography-coupled tandem mass 491	
spectrometry (HPLC-MS/MS) to accurately determine the concentration of second messen-492	
gers in cell extracts105,106, fluorescence-based reporters fused to c-di-GMP dependent promot-493	
ers or riboswitches107-110, and a c-di-GMP specific FRET probe that allows direct measure-494	
ments of c-di-GMP concentrations in individual live cells59,66. 495	
 496	
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Box 2: CDNs beyond c-di-GMP  498	
The CDN c-di-AMP was discovered as a ligand bound to the N-terminal domain of the 499	
DNA damage-sensing protein DisA of B. subtilis2. Biochemical studies identified this domain 500	
as diadenylate cylcase (DAC), the founding member of a family of enzymes that converts 501	
ATP to c-di-AMP. Specific PDEs associated with DHH-DHHA1 or HD domains hydrolyze c-502	
di-AMP into pApA or AMP111-113. C-di-AMP is essential in a variety of different bacteria and 503	
any dysregulation causes abnormal phenotypes114,115. A recent report suggested that in Lis-504	
teria monocytogenes this effect is due to overshooting levels of (p)ppGpp, a global second 505	
messenger linked to carbon metabolism and nutrient starvation116. C-di-AMP is associated 506	
with a growing list of cellular functions primarily in gram-positive bacteria. These include 507	
cell wall homeostasis115,117-120, DNA integrity2,121-123, potassium homeostasis104,124-126 and os-508	
moprotection127,128, gene expression129,130, biofilm formation131,132, sporulation133, metabo-509	
lism102, resistance to antibiotics134, and, similar to c-di-GMP, cell-mediated adaptive immune 510	
response (see below). 511	
c-GMP-AMP is of special interest because it is produced by bacteria and metazoans3,135. 512	
Bacterial c-GMP-AMP shows 3’-3’ linkage and is produced by the dinucleotide synthase 513	
DncV originally identified in V. cholera3. Structural studies revealed that in the first nucleo-514	
tidyl transfer reaction DncV preferably recognizes ATP and GTP as acceptor and donor nu-515	
cleotides, respectively136. c-GMP-AMP is required for host colonization by V. cholera and for 516	
exoelectrogenesis in different delta-proteobacteria137,138. Mammalian c-GMP-AMP (2’-3’) 517	
(cGAMP) has adopted a prominent role in a vertebrate innate immunity pathway responsible 518	
for surveillance of cytoplasmic DNA139. cGAMP is synthesized by the cGAMP synthase 519	
(cGAS), which is activated in response to binding cytoplasmic DNA140,141. cGAMP binds to 520	
and activates the host receptor STING which in turn recruits TANK-binding kinase 1 (TBK1) 521	
to phosphorylate IFN regulatory factor 3 (IRF3), ultimately leading to type I interferon (IFN) 522	
production. Evolutionary studies recently revealed that the cGAS-STING function is con-523	
served in anemone, which diverged from the human lineage more than 500 million years ago. 524	
Because Anemone cGAS produces a bacteria-like 3’-3’ linked CDN that is recognized by 525	
Anemone STING, it was proposed that cGAMP (2’-3’) is a recent vertebrate innovation and 526	
that during evolution the protein components of this pathway remained structurally conserved, 527	
while chemical changes in the second messenger were driving functional innovation142. 528	
Recent evidence suggests that c-di-GMP and c-di-AMP, secreted or released outside bac-529	
teria, are also sensed by STING (stimulator of interferon genes) thereby converging with the 530	
cGAS-cGAMP cytosolic DNA surveillance pathway143-145. Interestingly, bacteria seem to 531	
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have evolved strategies to dampen IFN production by avoiding STING activation. Group B 532	
Streptococcus was recently shown to express an ectonucleotidase, CdnP, which hydrolyzes 533	
extracellular bacterial c-di-AMP to attenuate the cGAS-STING axis146.  534	
 535	
 536	
 537	
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Figure legends 539	
Figure 1: Components of the c-di-GMP signaling network. (a) Principles of c-di-GMP 540	
signaling. Enzymatic reactions are depicted as grey arrows. GGDEF, EAL and HD-GYP rep-541	
resent conserved catalytic domains of diguanylate cyclases and phosphodiesterases, respec-542	
tively. (b) Schematic of DGC activation. Upper panel: phosphorylation-dependent activation 543	
of PleD from C. crescentus. Receiver-domains (Rec) are shown in green and GGDEF-544	
domains in orange. Phosphorylation-induced dimerization of Rec-domain stem leads to di-545	
merization and activation of GGDEF-domains. Lower panel: metal-dependent activation of E. 546	
coli DgcZ. DgcZ is a constitutive dimer. Zinc-depletion from the CZB-domain leads to com-547	
petent positioning of the GGDEF-domains. (c) Structure of the zinc-binding diguanylate 548	
cyclase DgcZ from E. coli (PDB: 4H54)22. GGDEF-domains (orange) and zinc-binding CZB-549	
domain (grey) are highlighted. Zinc metal ions are depicted as red spheres. C-di-GMP (ma-550	
genta) binding to antipodal inhibitory I-sites (IP & IP’) and GTPαS (green) binding to active 551	
sites (A & A’) are shown. (d) Overlay of the EAL domains of the phosphodiesterase PdeL in 552	
the tight, substrate-bound (blue; PDB: 4LJ3) and relaxed (apo) conformation (grey, PDB: 553	
4LYK)27. Inlet: zoom-in of the active site and conserved loop 6 region. The loop 6 confor-554	
mations in the relaxed, apo (yellow) and tight, c-di-GMP-bound (orange) dimer are indicated. 555	
Yellow and magenta spheres indicate the positions of Mg2+-ions in the relaxed and tight pro-556	
tein conformations, respectively. The conserved double-aspartic acid motif (D262, D263) and 557	
anchoring glutamate (E235), which determine the structural arrangement of loop 6 are high-558	
lighted. (e) Structure of Rhodobacter sphaeroides cellulose synthase complex with the BcsA 559	
subunit (green), its C-terminal PilZ-domain (magenta) and the BscB subunit (grey) (PDB: 560	
4P02) 46. The cytoplasmic membrane is outlined in grey. A dimer of c-di-GMP bound to the 561	
PilZ domain is marked.  562	
 563	
Figure 2: Role of c-di-GMP in C. crescentus pole morphogenesis and cell cycle progres-564	
sion. A schematic of the Caulobacter cell cycle is shown with flagellated swarmer cells (SW, 565	
G1-phase), stalked cells (ST, S-phase) and predivisional cells (division) indicated. Polar orga-566	
nelles (flagellum, pili, stalk and holdfast) of individual cell types are marked. The replication 567	
status of the circular chromosome is indicated schematically with SW cells being replication 568	
silent while chromosome replication initiates in ST cells. Cell type-specific levels of c-di-569	
GMP are as indicated. The subcellular localization of the DGC PleD, the PDE PdeA, the fla-570	
gellar placement protein TipF and the sensor histidine kinases PleC, DivJ and CckA are 571	
	 20	
marked at individual stages of the cell cycle. Individual panels highlight stage-specific pro-572	
cesses at the stalked and flagellated poles. Autophosphorylation of histidine kinases (DivJ, 573	
CckA) and phosphotransfer to response regulators (PleD, CtrA) are indicated. a) Flagellar as-574	
sembly. TipF binds to c-di-GMP to localize to the flagellated pole, where it recruits flagellar 575	
components PflI and FliG to initiate flagellar assembly. b) Low c-di-GMP levels at the flagel-576	
lated pole of dividing cells and in SW cells promote TipF degradation by the ClpXP protease 577	
and CckA kinase activity. The CckA kinase activates the CtrA replication initiation inhibitor 578	
by phosphorylation via the P-transfer protein ChpT. PdeA and as yet unidentified PDE(s) con-579	
tribute to the reduction of the c-di-GMP concentration at this cell cycle stage.  c) Degradation 580	
of PdeA and CtrA by the ClpXP protease during the SW-to-ST transition and at the stalked 581	
pole of the dividing cell. PleD and as yet unidentified DGC(s) contribute to the upshift of c-582	
di-GMP upon entry into S-phase and in the predivisional cell. Activation of the protease adap-583	
tor PopA by c-di-GMP leads to the degradation of CtrA. d) Inactivation of CtrA by the CckA 584	
phosphatase during the SW-to-ST transition and at the stalked pole of the dividing cell. PleD 585	
and as yet unidentified DGC(s) contribute to the upshift of c-di-GMP upon entry into S-phase 586	
and in the predivisional cell. Binding of c-di-GMP causes the switch of the CckA histidine ki-587	
nase from its default kinase to the S-phase-specific phosphatase state. 588	
 589	
Figure 3: Role of c-di-GMP in biofilm formation and dispersal. Bacterial surface attach-590	
ment, biofilm formation and dispersal are indicated schematically in the central panel. (a) c-591	
di-GMP-mediated control of flagellar motility in E. coli. DGCs (orange), PDE (blue) and the 592	
c-di-GMP effector YcgR (purple) are highlighted. YcgR interacts with and curbs the flagellar 593	
motor upon binding of c-di-GMP. PdeH adopts a key role to inactivate YcgR by keeping c-di-594	
GMP levels low thereby enabling motor function. (b) c-di-GMP-dependent production of am-595	
yloid curli fibers and cellulose in E. coli. The global (DgcE/PdeH) and local (DgcM/PdeR) 596	
modules of DGCs and PDEs controlling csgD transcription are indicated. DgcM/PdeR sense 597	
the global concentration of c-di-GMP and, in response, activate the transcription factor MlrA. 598	
The global transcription factor CsgD then activates the expression of curli components and of 599	
DgcC, the main activator of the cellulose synthase complex. (c) c-di-GMP-mediated synthesis 600	
of poly-beta-1,6-N-acetyl-glucosamine (GlcNAc) in E. coli. The Csr global regulatory system 601	
co-regulates the pga genes encoding components of the GlcNAc synthesis machinery (PgaA-602	
D) and dgcT and dgcZ encoding two DGCs (orange) responsible for the allosteric activation 603	
of PgaCD. The histidine kinase BarA is stimulated by short-chain fatty acids and through the 604	
phosphorylation of the response regulator UvrY, activates the expression of two small RNAs, 605	
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CsrB and CsrC, which in turn antagonize the translation inhibitor CsrA. (d) Biofilm escape 606	
mechanism in P. fluorescens Pf0-1. The LapA surface protein mediates P. fluorescens surface 607	
adhesion and contributes to the stabilization of biofilms. Under phosphate starvation condi-608	
tions LapA is degraded by the periplasmic protease LapG resulting in biofilm escape. If 609	
enough phosphate is available, LapG is sequestered by its partner LapD in its c-di-GMP 610	
bound conformation. When phosphate becomes limited the RapA PDE is expressed through 611	
the phosphate control system Pst/PhoRB, leading to a drop of c-di-GMP, a conformational 612	
change of apo-LapD and the release of the protease. 613	
 614	
 615	
Figure 4: Role of c-di-GMP in virulence of Clostridium difficile. C. difficile virulence is 616	
regulated by c-di-GMP-specific riboswitches. Type-I riboswitches and type-II riboswitches 617	
control the expression of factors involved in motility, surface attachment and virulence. Type-618	
I riboswitches (OFF-switches) inhibit translation upon c-di-GMP binding, while type-II-619	
riboswitches (ON-switches) promote translation of target genes when bound to c-di-GMP. In-620	
creasing levels of c-di-GMP stimulate the expression of adhesion factors such as type-4-pili 621	
(T4P) and collagen-binding proteins (CBP) and inhibit the expression of flagellar genes and 622	
the CBP protease. The gene encoding the sigma factor SigD is co-regulated with flagellar 623	
genes. Thus, when the c-di-GMP concentration is low, cells not only express motility and an-624	
ti-adhesion genes, but also express the SigD-dependent Cdiff toxins TcdA and TcdB. 625	
 626	
 627	
Figure 5: General concepts of c-di-GMP signaling modules. Effectors (E) (c-di-GMP bind-628	
ing proteins), diguanylate cyclases (DGC) and phosphodiesterases (PDE) are labeled. c-di-629	
GMP molecules are indicated as black circles or as spatial gradient in (c). (a) Evolutionary di-630	
agram of recruiting cellular processes into an existing CDN network. Minor modifications of 631	
the surface of a specific protein can mediate specific binding of c-di-GMP, which in turn can 632	
modulate the protein’s activity, stability or interaction with a partner. (b) and (c) Network ar-633	
chitecture involved in pathway-specific signaling. C-di-GMP-dependent processes can be 634	
specifically regulated by temporal (b) or spatial (c) separation. Temporal regulation relies on 635	
effector proteins with different ligand affinities and on DGCs and/or PDEs with specific inhi-636	
bition and activation constants, respectively. This allows establishing precise cellular thresh-637	
olds of c-di-GMP thereby activating specific downstream effectors and pathways. Spatially 638	
separated signaling relies on some form of compartmentalization, for example with a specific 639	
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DGC/PDEs module interacting with its specific effector. To avoid unwanted crosstalk with 640	
other effectors and cellular pathways, spatially confined modules need to be effectively insu-641	
lated. This can occur via the action of the module-specific PDE or by a general cellular PDE 642	
that restrains leakage of c-di-GMP. (d) C-di-GMP can interfere with the same biological pro-643	
cess at different levels of control. E.g. c-di-GMP can control gene expression (transcrip-644	
tion/translation) or control the activity of one of the resulting proteins as indicated. Expression 645	
and allosteric control can be mediated by the same module comprising a DGC and PDE (ar-646	
rows) or can be modulate independently by different DGC/PDEs modules.  647	
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